Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.
Press releases published on July 31, 2025
BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December
GlobeNewswire
·
July 31, 2025
RESEARCH TRIANGLE PARK, N.C., July 31, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its president and chief executive officer, Jon Stonehouse, has informed the board of directors of his intention to retire on …
Medicenna Strengthens Intellectual Property Portfolio with Five Patents Granted for its IL-2 and IL-4 Superkines
GlobeNewswire
·
July 31, 2025
TORONTO and HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing novel Superkines for oncology and autoimmune diseases, today …
Oroco Deepens its ESG Commitments to the Santo Tomás Region
GlobeNewswire
·
July 31, 2025
VANCOUVER, Canada, July 31, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or “the Company”) is pleased to announce it has signed a cooperation agreement with Sembrando Vida (“Sowing Life”), a flagship environmental and …
XORTX Announces USD $114,500 Private Placement
GlobeNewswire
·
July 31, 2025
CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and …
Voluntary TSX delisting application
GlobeNewswire
·
July 31, 2025
TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) ACN 114 249 026 (Xanadu or the Company) refers to its previous announcement released on 29 July 2025 (Announcement) regarding the Compulsory Acquisition Notice provided by …
Agios Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
July 31, 2025
$12.5 million in second quarter PYRUKYND® (mitapivat) net revenues; ended second quarter with $1.3 billion dollars in cash, cash equivalents and marketable securities PYRUKYND sNDA for thalassemia under active review, with FDA PDUFA goal date of September …
Niio Launches Streaming Art & Signage Service, Bringing Curated Visual Art Experiences to Every Screen
GlobeNewswire
·
July 31, 2025
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Niio, the world’s leading platform for streaming curated digital art, today announces the launch of its new Art …
PL BioScience Announces Major Site Expansion
GlobeNewswire
·
July 31, 2025
New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate production Site provides the world’s largest HPL output with 20,000L annual capacity and a dual-source GMP strategy for secure, resilient supply …
Pharming Group reports second quarter and first half 2025 financial results and provides business update
GlobeNewswire
·
July 31, 2025
Second quarter 2025 total revenues increased by 26% to US$93.2 million, compared to the second quarter 2024, driven by strong RUCONEST® and Joenja® revenue growth RUCONEST® second quarter revenue increased by 28% to US$80.4 million, compared to the second …